Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ...
As the year-end party season gets into full swing, social drinking events are on the rise. Frequent drinking can go beyond ...
MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company's First FDA-Approv ...
At a Bengaluru-based therapy centre, a middle-aged man with alcohol dependence showed marked improvement in foot drop & liver ...
Keeping up with the world of biotech can feel like a full-time job, right? There’s always something new happening, from ...
A science-backed guide to building a smarter CBD and THC wellness routine in 2025, covering sleep, stress, pain, safety, and product quality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback